AML patient samples exhibited lower PP2A activity compared to BM mononuclear cells isolated from healthy donors (NBM 4.60 ± 0.3 v's AML 2.83 ± 0.2 PO4/μg, p = 0.015) (Figure 3A). This evidence concerns the gene PTPA and acute myeloid leukemia.